BCAN Launches $1 Million Continuity Grant to Sustain Bladder Cancer Research
The Funding Continuity Grant was created to ensure that high-quality bladder cancer research—previously peer-reviewed, approved and funded—can move forward without interruption. It comes in addition to the
"We have seen incredible momentum in bladder cancer research and it's important to continue to make progress," said
Amid uncertainty in federal funding, these grants will provide a crucial bridge to keep vital research moving forward. Deoudes added, "For 20 years, BCAN has been dedicated to creating better todays and more tomorrows for bladder cancer patients and families, and this continuity grant builds on that longstanding commitment."
The situation is urgent: this year alone, more than 84,000 people will receive a bladder cancer diagnosis and the disease disproportionately impacts communities like our nation's veterans.
The grant is open to investigators at
To learn more about the Funding Continuity Grant, visit https://bcan.org/research-continuity-grants/.
The Bladder Cancer Advocacy Network, or BCAN, was founded in 2005 and provides patients with the critical information and community support they need to thrive today – and champions innovative research and responsive national policy to inspire hope for tomorrow.
View original content:https://www.prnewswire.com/news-releases/bcan-launches-1-million-continuity-grant-to-sustain-bladder-cancer-research-302499661.html
SOURCE The Bladder Cancer Advocacy Network
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- A Green Beret's Humanitarian Mission to Remove Ukraine's Landmines Now Streaming on Prime Video in the U.S. and UK
- Licensed Producer Dmitry Borovoy Launches SafeBridge, a Bilingual Trucking Insurance Desk for New Carriers
- USPS Salutes the U.S. Coast Guard Academy's 150 Years
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share